
A little portfolio haircut
Mirae Asset Global Investments decided Merck deserved a slightly smaller slice of the pie, cutting 178,997 shares and leaving it with 1,881,532 shares worth about $198.05 million. That still makes Merck Mirae’s 26th-largest holding, so this is more “trim the hedge” than “run for the exits.”
Why you should care
When institutions adjust a position, the market likes to squint and ask: is this a signal or just portfolio housekeeping? In this case, it looks pretty tame. Mirae still has plenty of skin in the game, which suggests the fund hasn’t suddenly lost faith in Merck’s story.
The bigger Merck backdrop
The article also reminds readers that Merck recently:
- posted Q4 earnings of $2.04 a share, topping estimates
- generated $16.40 billion in revenue, also ahead of expectations
- guided FY 2026 EPS to $5.00-$5.15
- paid its quarterly dividend on April 7
So yeah, this isn’t some panic-driven fire sale. It’s more like a small rebalancing move in a stock that’s still throwing off cash and paying shareholders along the way.
Big picture: unless more big holders start heading for the door, this looks like garden-variety portfolio management — not a red flare over Merck’s fundamentals.
